E-cadherin and alpha-, beta- and gamma-catenin expression in prostate cancers: correlation with tumour invasion
- PMID: 10206308
- PMCID: PMC2362820
- DOI: 10.1038/sj.bjc.6690299
E-cadherin and alpha-, beta- and gamma-catenin expression in prostate cancers: correlation with tumour invasion
Abstract
The E-cadherin-catenin complex plays an important role in establishing and maintaining intercellular connections and morphogenesis and reduced expression of its constituent molecules is associated with invasion and metastasis. In the present study, we examined E-cadherin and alpha-, beta- and gamma-catenin levels in tumour tissues obtained by radical prostatectomy in order to investigate the relationship with histopathological tumour invasion. Immunohistochemical findings for 45 prostate cancer specimens demonstrated aberrant expression of each molecule to be associated with dedifferentiation and, in addition, alteration of staining patterns for the three types of catenin was significantly correlated with capsular but not lymphatic or vascular invasion. The data thus suggest that three types of catenin may be useful predictive markers for biological aggressiveness of prostate cancer.
Similar articles
-
Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.Anticancer Res. 2001 Nov-Dec;21(6A):4127-34. Anticancer Res. 2001. PMID: 11911306
-
Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.J Pathol. 2000 Dec;192(4):433-9. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH723>3.0.CO;2-V. J Pathol. 2000. PMID: 11113859
-
Reduced expression of molecules of the cadherin/catenin complex in the transition from colorectal adenoma to carcinoma.Anticancer Res. 1997 May-Jun;17(3C):2241-7. Anticancer Res. 1997. PMID: 9216695
-
E-cadherin/catenin/cytoskeleton complex: a regulator of cancer invasion.J Cell Physiol. 1997 Nov;173(2):271-4. doi: 10.1002/(SICI)1097-4652(199711)173:2<271::AID-JCP34>3.0.CO;2-G. J Cell Physiol. 1997. PMID: 9365535 Review. No abstract available.
-
The cadherin cell-cell adhesion pathway in prostate cancer progression.Br J Urol. 1997 Mar;79 Suppl 1:37-43. doi: 10.1111/j.1464-410x.1997.tb00799.x. Br J Urol. 1997. PMID: 9088271 Review.
Cited by
-
Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline.Br J Cancer. 2005 Jan 31;92(2):366-75. doi: 10.1038/sj.bjc.6602350. Br J Cancer. 2005. PMID: 15655536 Free PMC article.
-
Ormeloxifene Suppresses Prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic β-catenin Signaling and EMT Progression.Mol Cancer Ther. 2017 Oct;16(10):2267-2280. doi: 10.1158/1535-7163.MCT-17-0157. Epub 2017 Jun 14. Mol Cancer Ther. 2017. PMID: 28615299 Free PMC article.
-
Small RNA-induced INTS6 gene up-regulation suppresses castration-resistant prostate cancer cells by regulating β-catenin signaling.Cell Cycle. 2018;17(13):1602-1613. doi: 10.1080/15384101.2018.1475825. Epub 2018 Aug 2. Cell Cycle. 2018. PMID: 29895194 Free PMC article.
-
Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration.Hepatology. 2001 May;33(5):1098-109. doi: 10.1053/jhep.2001.23786. Hepatology. 2001. PMID: 11343237 Free PMC article.
-
Epithelial-mesenchymal transition in breast epithelial cells treated with cadmium and the role of Snail.Toxicol Appl Pharmacol. 2018 Apr 1;344:46-55. doi: 10.1016/j.taap.2018.02.022. Epub 2018 Mar 6. Toxicol Appl Pharmacol. 2018. PMID: 29501589 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous